This paper is in the following e-collection/theme issue:

Non-randomized Protocols and Methods (ehealth) (568) Quantified Self and Wellness (77) mHealth for Wellness, Behavior Change and Prevention (2875) Apps, Mobile, Wearables for Diabetes (298) Clinical or Consumer-Focused Software for Diabetes (18) Crowdsourcing, Big Data, Quantified Self-based Research Data (9) Psychosocial Effects of Diabetes and Support for People with Diabetes (17)

Published on in Vol 10, No 1 (2021): January

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/21727, first published .
Evaluation of Self-Care Activities and Quality of Life in Patients With Type 2 Diabetes Mellitus Treated With Metformin Using the 2D Matrix Code of Outer Drug Packages as Patient Identifier: Protocol for the DePRO Proof-of-Concept Observational Study

Evaluation of Self-Care Activities and Quality of Life in Patients With Type 2 Diabetes Mellitus Treated With Metformin Using the 2D Matrix Code of Outer Drug Packages as Patient Identifier: Protocol for the DePRO Proof-of-Concept Observational Study

Evaluation of Self-Care Activities and Quality of Life in Patients With Type 2 Diabetes Mellitus Treated With Metformin Using the 2D Matrix Code of Outer Drug Packages as Patient Identifier: Protocol for the DePRO Proof-of-Concept Observational Study

Authors of this article:

Christian Mueller1 Author Orcid Image ;   Isabel Schauerte2 Author Orcid Image ;   Stephan Martin3 Author Orcid Image
Article Authors Cited by (5) Tweetations (1) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.